Biocon Biologics honored as 2025 Asia IP Elite by IAM for 9th consecutive year
This recognition demonstrate excellence in intellectual property (IP) value creation.
This recognition demonstrate excellence in intellectual property (IP) value creation.
The FDA has classified recent submissions as a major amendment pushing the approval to its NDA for TransCon CNP back three months to February 28, 2026
The Eurasian Patent Organization (EAPO) has granted Patent, protecting the company’s sublingual delivery technology for anticancer drugs used to treat autoimmune and neurodegenerative diseases
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
AINU is set to accelerate its expansion footprint, enhance operational capabilities
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia
Changhua site meets international regulatory standards for global medical applications
Subscribe To Our Newsletter & Stay Updated